Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FRVZH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,687
Award facts
- Contract value 100% obligated
- $4,687.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $4,687.18 for Tezspire 210 mg/1.91 mL pen injectors. The contract, issued on April 25, 2025, with an ultimate completion date of May 16, 2025, represents a firm fixed-price delivery order under no set-aside designation. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
The supply of Tezspire, a biologic medication for eosinophilic asthma, falls within AmerisourceBergen's established portfolio of specialty medications provided through the DLA Medical Supply Chain. The Defense Logistics Agency procures medical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen demonstrating consistent capability to fulfill federal pharmaceutical procurement requirements through competitive award processes and firm fixed-price delivery orders across a broad range of therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FRVZH?
SPE2DB25FRVZH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 25, 2025.
How much is contract SPE2DB25FRVZH worth?
The government has obligated $4,687 on SPE2DB25FRVZH.
Is contract SPE2DB25FRVZH an order under another contract?
Yes. SPE2DB25FRVZH is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRVZH competed?
The extent of competition for SPE2DB25FRVZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award